<DOC>
	<DOCNO>NCT03022552</DOCNO>
	<brief_summary>This prospective observational cohort study , investigate platelet phenotype , platelet genetic composition , role platelet effector cell woman myocardial infarction ( MINOCA MI-CAD ) control . This study , take place NYU Bellevue Medical Center , may concurrent enrollment HARP Main Imaging ( NCT02914483 ) HARP Stress Ancillary Studies ( NCT02270359 ) . Additionally , group age race match disease control 'CATH-NOCA ' compose woman stable angina refer cardiac catheterization , enrol . Blood obtain initial catheterization , 2 month post-MI , follow stress study ( participant enrol stress study ) utilize platelet testing .</brief_summary>
	<brief_title>Women 's Heart Attack Research Program : Platelet Sub-Study ( HARP )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Acute ischemic symptom compatible diagnosis MI , chest pain anginal equivalent symptom rest new onset exertional anginal equivalent symptom Objective evidence MI ( either follow ) : Elevation troponin laboratory upper limit normal ( ULN ) ST segment elevation ≥1mm 2 contiguous ECG lead Willing provide inform consent comply aspects protocol Age ≥ 21 year Female sex Administration aspirin least 1 hour cardiac catheterization Administration thienopyridine ( e.g. , clopidogrel , ticagrelor ) least 1 hour cardiac catheterization Women ≥50 % major epicardial vessel invasive angiography may participate Recent use vasospastic agent , cocaine , triptans , ergot alkaloid ( ≤1 month ) Alternate explanation troponin elevation , hypertensive urgency , acute exacerbation heart failure , chronic elevation due kidney disease , pulmonary embolism , cardiac trauma Pregnancy Thrombolytic therapy STEMI ( qualify event ) Use follow medication : Platelet antagonist ( except aspirin thienopyridines ) within 7 day NSAIDs ( e.g. , ibuprofen , naproxen ) within 3 day . Thrombocytopenia ( platelet count &lt; 100,000 ) Thrombocytosis ( platelet count &gt; 500,000 ) Anemia ( hemoglobin &lt; 9 mg/dl ) Hemorrhagic diathesis</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Women</keyword>
	<keyword>Platelets</keyword>
	<keyword>Blood Collection</keyword>
	<keyword>Genomics</keyword>
</DOC>